Obesity Drugs Trail Surgical Methods in Total Weight Loss and Sustainability, Insurers Lean Toward Latter
![](https://www.mcalindenresearchpartners.com/wp-content/uploads/2024/06/piron-guillaume-iwzaTMpBD7Q-unsplash-1024x683.jpg)
New study data indicates that the popularity of GLP-1 injectables from Eli Lilly and Novo Nordisk continues to be overshadowed…
McAlinden Research PartnersJune 17, 2024